1Ciecarelli A, Daly AF, Beckers A. The epidemiology of prolactinomas [J]. Pituitary, 2005, 8(1): 3-6.
2Korbonits M, Carlsen E. Recent clinical and pathophysiological advances in non-functioning pituitary adenomas [ J]. Horm Res, 2009, 71 Suppl2:123-130.
3Gibneg J, Smith TP, McKenna TJ. Clinical relevance of macroprolactin [J]. Clin Endocrinal (Oxf), 2005, 62(6): 633-643.
4Fahie-Wilson MN, John R, Ellis AR. Macroprolactin; high molecular mass forms of circulating prolactin [J]. Ann Clin Biochem, 2005, 42 (Pt3) : 175 -192.
5Smith TP, Suliman AM, Fahie-Wilson MN, et al. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays [ J]. J Clin Endocrinol Metab, 2002, 87(12) : 5410 -5415.
6Jeske W, Zgliczynski W, Zdunowski P. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method [ J]. J Clin Endocrinol Metab,2002, 87(4) : 1909 -1910.
7Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolaetinomas [ J ]. Clin Endocrinol (Oxf), 2006, 65 (2) : 265 - 273.
8Karavitaki N, Thanabalasingham G, Shore HC, et al. Do the limits of serum prolaetin in diseonneetion hyperprolaetinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary maeroadenoma [ J]. Clin Endoerinol ( Oxf), 2006, 65 (4) : 524 - 529.
9Salehi F, Kovacs K, Scheithauer BW, et al. Immunohistochemieal expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas : a correlative study of tumor subtypes [ J]. Int J Surg Pathol, 2010, 18(1) : 5 -13.
